Literature DB >> 21862681

The extended granin family: structure, function, and biomedical implications.

Alessandro Bartolomucci1, Roberta Possenti, Sushil K Mahata, Reiner Fischer-Colbrie, Y Peng Loh, Stephen R J Salton.   

Abstract

The chromogranins (chromogranin A and chromogranin B), secretogranins (secretogranin II and secretogranin III), and additional related proteins (7B2, NESP55, proSAAS, and VGF) that together comprise the granin family subserve essential roles in the regulated secretory pathway that is responsible for controlled delivery of peptides, hormones, neurotransmitters, and growth factors. Here we review the structure and function of granins and granin-derived peptides and expansive new genetic evidence, including recent single-nucleotide polymorphism mapping, genomic sequence comparisons, and analysis of transgenic and knockout mice, which together support an important and evolutionarily conserved role for these proteins in large dense-core vesicle biogenesis and regulated secretion. Recent data further indicate that their processed peptides function prominently in metabolic and glucose homeostasis, emotional behavior, pain pathways, and blood pressure modulation, suggesting future utility of granins and granin-derived peptides as novel disease biomarkers.
Copyright © 2011 by The Endocrine Society

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21862681      PMCID: PMC3591675          DOI: 10.1210/er.2010-0027

Source DB:  PubMed          Journal:  Endocr Rev        ISSN: 0163-769X            Impact factor:   19.871


  429 in total

1.  The SAAS granin exhibits structural and functional homology to 7B2 and contains a highly potent hexapeptide inhibitor of PC1.

Authors:  A Cameron; Y Fortenberry; I Lindberg
Journal:  FEBS Lett       Date:  2000-05-12       Impact factor: 4.124

Review 2.  Biomarkers and surrogate endpoints: preferred definitions and conceptual framework.

Authors: 
Journal:  Clin Pharmacol Ther       Date:  2001-03       Impact factor: 6.875

3.  Visualization of sequential exocytosis in rat pancreatic islet beta cells.

Authors:  Yuk Man Leung; Laura Sheu; Edwin Kwan; Guotang Wang; Robert Tsushima; Herbert Gaisano
Journal:  Biochem Biophys Res Commun       Date:  2002-04-12       Impact factor: 3.575

4.  Measurements of chromogranin B can serve as a complement to chromogranin A.

Authors:  Mats Stridsberg; Barbro Eriksson; Bengt Fellström; Gudjon Kristiansson; Eva Tiensuu Janson
Journal:  Regul Pept       Date:  2006-11-20

5.  The chromogranin A peptide vasostatin-I inhibits gap formation and signal transduction mediated by inflammatory agents in cultured bovine pulmonary and coronary arterial endothelial cells.

Authors:  Anna Blois; Boleslaw Srebro; Maurizio Mandalà; Angelo Corti; Karen B Helle; Guldborg Serck-Hanssen
Journal:  Regul Pept       Date:  2006-05-24

Review 6.  Immunohistochemical and biochemical studies with region-specific antibodies to chromogranins A and B and secretogranins II and III in neuroendocrine tumors.

Authors:  Guida M Portela-Gomes; Lars Grimelius; Mats Stridsberg
Journal:  Cell Mol Neurobiol       Date:  2010-11-03       Impact factor: 5.046

Review 7.  New insights into granin-derived peptides: evolution and endocrine roles.

Authors:  E Zhao; Dapeng Zhang; Ajoy Basak; Vance L Trudeau
Journal:  Gen Comp Endocrinol       Date:  2009-01-31       Impact factor: 2.822

8.  Prognostic value of plasma chromogranin A levels in patients with complicated myocardial infarction.

Authors:  Mette Elise Estensen; Aina Hognestad; Unni Syversen; Iain Squire; Leong Ng; John Kjekshus; Kenneth Dickstein; Torbjørn Omland
Journal:  Am Heart J       Date:  2006-11       Impact factor: 4.749

Review 9.  Chromogranin A: a novel susceptibility gene for essential hypertension.

Authors:  Bhavani S Sahu; Parshuram J Sonawane; Nitish R Mahapatra
Journal:  Cell Mol Life Sci       Date:  2009-11-27       Impact factor: 9.261

10.  Peptide products of the neurotrophin-inducible gene vgf are produced in human neuroendocrine cells from early development and increase in hyperplasia and neoplasia.

Authors:  Guido Rindi; Lisa Licini; Vittorio Necchi; Lorena Bottarelli; Nicoletta Campanini; Cinzia Azzoni; Maurizio Favret; Giovanna Giordano; Filomena D'Amato; Carla Brancia; Enrico Solcia; Gian-Luca Ferri
Journal:  J Clin Endocrinol Metab       Date:  2007-04-17       Impact factor: 5.958

View more
  124 in total

Review 1.  New roles of carboxypeptidase E in endocrine and neural function and cancer.

Authors:  Niamh X Cawley; William C Wetsel; Saravana R K Murthy; Joshua J Park; Karel Pacak; Y Peng Loh
Journal:  Endocr Rev       Date:  2012-03-07       Impact factor: 19.871

Review 2.  Brain-expressed imprinted genes and adult behaviour: the example of Nesp and Grb10.

Authors:  Claire L Dent; Anthony R Isles
Journal:  Mamm Genome       Date:  2013-08-24       Impact factor: 2.957

3.  Clearance kinetics of the VGF-derived neuropeptide TLQP-21.

Authors:  ZengKui Guo; Bhavani S Sahu; Rongjun He; Brian Finan; Cheryl Cero; Raffaello Verardi; Maria Razzoli; Gianluigi Veglia; Richard D Di Marchi; John M Miles; Alessandro Bartolomucci
Journal:  Neuropeptides       Date:  2018-06-19       Impact factor: 3.286

4.  Identification of chondroitin sulfate linkage region glycopeptides reveals prohormones as a novel class of proteoglycans.

Authors:  Fredrik Noborn; Alejandro Gomez Toledo; Carina Sihlbom; Johan Lengqvist; Erik Fries; Lena Kjellén; Jonas Nilsson; Göran Larson
Journal:  Mol Cell Proteomics       Date:  2014-10-17       Impact factor: 5.911

5.  Chronic nicotine treatment impacts the regulation of opioid and non-opioid peptides in the rat dorsal striatum.

Authors:  Filomena Petruzziello; Sara Falasca; Per E Andren; Gregor Rainer; Xiaozhe Zhang
Journal:  Mol Cell Proteomics       Date:  2013-02-22       Impact factor: 5.911

6.  Expanding the chondroitin glycoproteome of Caenorhabditis elegans.

Authors:  Fredrik Noborn; Alejandro Gomez Toledo; Waqas Nasir; Jonas Nilsson; Tabea Dierker; Lena Kjellén; Göran Larson
Journal:  J Biol Chem       Date:  2017-11-14       Impact factor: 5.157

7.  Large-scale identification of endogenous secretory peptides using electron transfer dissociation mass spectrometry.

Authors:  Kazuki Sasaki; Tsukasa Osaki; Naoto Minamino
Journal:  Mol Cell Proteomics       Date:  2012-12-18       Impact factor: 5.911

8.  Impact of Chromogranin A deficiency on catecholamine storage, catecholamine granule morphology and chromaffin cell energy metabolism in vivo.

Authors:  Teresa Pasqua; Sumana Mahata; Gautam K Bandyopadhyay; Angshuman Biswas; Guy A Perkins; Amiya P Sinha-Hikim; David S Goldstein; Lee E Eiden; Sushil K Mahata
Journal:  Cell Tissue Res       Date:  2015-11-16       Impact factor: 5.249

Review 9.  Secretogranin III: a diabetic retinopathy-selective angiogenic factor.

Authors:  Wei Li; Keith A Webster; Michelle E LeBlanc; Hong Tian
Journal:  Cell Mol Life Sci       Date:  2017-08-30       Impact factor: 9.261

10.  Complement 3a receptor in dorsal horn microglia mediates pronociceptive neuropeptide signaling.

Authors:  Suzanne Doolen; Jennifer Cook; Maureen Riedl; Kelley Kitto; Shinichi Kohsaka; Christopher N Honda; Carolyn A Fairbanks; Bradley K Taylor; Lucy Vulchanova
Journal:  Glia       Date:  2017-08-29       Impact factor: 7.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.